cost per patient and budget impact prediction of denosumab versus zoledronic acid in prevention of...
DESCRIPTION
Lothgren Mickael, Cristino Joaquim, Lundkvist Jonas, Vrouchou Polina, Bracco Andrea, Pereira João Cost Per Patient And Budget Impact Prediction Of Denosumab Versus Zoledronic Acid In Prevention Of Skeletal-Related Events (SREs) In Patients With Bone Metastases From Solid Tumours In Portugal And SwedenTRANSCRIPT